x
ServiziMenu principaleHome
You are here: Home > Events > Past events > 2017 > 16th ESO-ESMO Masterclass in Clinical Oncology
Print

16th ESO-ESMO Masterclass in Clinical Oncology

25.03.2017  -  30.03.2017

Nauen OT Groß Behnitz (Berlin area), Germany

MASTERCLASS

Medical/Clinical Oncology

Description

Chairs: N. Pavlidis, GR - R.A. Stahel, CH
Scientific Advisors: F. Lordick, DE - R. Popescu, CH


AIMS AND OBJECTIVES
This clinically oriented educational programme has been designed for medical or clinical oncologists who wish to improve their skills or those who are preparing for the national board exam.
The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-oriented training. The programme focuses on breast, colorectal, lung, genito-urinary, gynaecological, head and neck cancers.
Spotlight sessions will facilitate compact update on communication skills, supporting and palliative care, immunotherapy, melanoma, sarcomas and GIST, treatment of elderly cancer patients, molecular tumour boards, magnitude of benefits scale, drug availability, biosimilars, Adolescents and young adults, different roles in the oncology team, ethical dilemmas, low and high grade lymphomas, physical activity.


TEACHING FORMAT
The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will conclude in take-home messages. Participants will deliver case presentations within tumour boards and small groups and discuss them with the chairmen and the faculty. Informal discussion will be facilitated during the aperitifs with the expert.
All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and fluency in English is necessary for admission. Participants of the concomitant Masterclass in Nursing Oncology will attend selected medical sessions whilst the communication skills sessions will be attended jointly.


THE MASTERCLASS IS
• A 5-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering lectures focusing on genito-urinary, breast, gynaecological, head and neck, gastro-intestinal and lung cancers.


ACCREDITATION
Application for CME recognition will be submitted to the European Society for Medical Oncology (ESMO) for ESMO-MORA accreditation, to the Accreditation Council of Oncology in Europe (ACOE) and to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the applications can be obtained from the organising secretariat.



    

The Masterclass in
Clinical Oncology is an
ESO-ESMO joint event

   
    
    

The Masterclass is held
in collaboration with the
Flims Alumni Club

  
    
    

The 2017 Masterclass is part of
the Masterclass-Online Study
Program in Advanced Oncology
of the University of Ulm

   
    
    
    
    

General information

ORGANISING SECRETARIAT                       
Francesca Marangoni                            
Ph: +39 02 85464525                           
Email: fmarangoni@eso.net                        
European School of Oncology
Via Turati, 29
20121 Milan, Italy
Fax: +39 02 85464545


Applications
Corinne Hall
Ph: +39 02 85464522
Email: chall@eso.net


ACCREDITATION

Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE) and to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). Information on the status of the applications can be obtained from the organising secretariat.
Furthermore, the conference has been accredited with 25 ESMO-MORA category 1 points.



ACKNOWLEDGEMENTS
The Masterclass is part of the Sharing Progress in Cancer Care programme whose sustaining members are (as of July 2016):
• Platinum member: Bristol-Myers Squibb
• Gold members: Eli Lilly, Genomic Health, Helsinn, Merck KGaA, Darmstadt, Germany, Pfizer and Roche
Silver members: Bayer, Boehringer Ingelheim, Celgene Corporation, Novartis Oncology, Sandoz Biopharmaceutical and Sanofi




Faculty list


FACULTY
(as of July 2016)

M. Aapro
, Clinique de Genolier, Oncology Dpt., Genolier, CH
M. Annoni, European Institute of Oncology, Dept. of Biomedical Humanities, Milan, IT
A. Arber
, University of Surrey, Faculty of Health and Medical Sciences, Guildford, UK
P. Casali, National Cancer Institute, Medical Oncology Dept., Milan, IT
A. Cervantes Ruiperez, Hospital Clinico Universitario de Valencia - INCLIVA, Haematology and Medical Dept., Valencia, ES
G. Curigliano, European Institute of Oncology, Department of Medicine, Division of Experimental Therapeutics, Milan, IT
A. Dietz, University Hospital Leipzig, ENT Department, Leipzig, DE   
M. Dreyling, University Hospital Grosshadern, Dept. of Hematology-Oncology, Munich, DE
A. Eniu
, Cancer Institute Ion Chiricuta, Dept. of  Breast Cancer, Cluj-Napoca, RO
C. Faivre-Finn
, The Christie and University of Manchester, Institute of Cancer Sciences, Manchester, UK
K. Fizazi, Institut Gustave Roussy, Dept. of Cancer Medicine, Villejuif, FR
W. Gatzemeier, Humanitas Cancer Center, Breast Unit, Rozzano, IT
S. Gillessen, Kantospital St. Gallen, Onco-Haematology Clinic, St Gallen, CH       
B. Grube, Danish Nurses Organisation, Dept. of Education fro Advanced Cancer Nurses, Copenhagen, DK
S. Hillinger
, University Hospital Zurich, Dept. of Thoracic Surgery, Zurich, CH   
A. Hoy
, Consultant in Palliative Medicine, Epsom, UK United Kingdom
F. Lordick, University Hospital Leipzig, University Cancer Center Leipzig, Leipzig, DE  
P. Maugeri, European Institute of Oncology, Dept. of Biomedical Humanities, Milan, IT
G. Mountzios
, 251 Airforce General Hospital, Dept. of Medical Oncology, Athens, GR   
O. Michielin, Lausanne University Hospital - CHUV, Dept. of Medical Oncology, Lausanne, CH   
R. Orecchia, Istituto Europeo di Oncologia, Div. di Radioterapia, Milan, IT  
O. Pagani, Oncology Institute of Southern Switzerland (IOSI); Breast Unit, Bellinzona, CH   
N. Pavlidis, University Hospital of Ioannina, Div. of Medical Oncology, Ioannina, GR
F. Peccatori, European Institute of Oncology, Dept. of Fertility and Procreation in Oncology, Milan, IT   
S. Peters, Centre Hospitalier Universitaire Vaudois, Dept. of Oncology, Lausanne, CH  
R. Popescu, Hirslanden Klinik Aarau, Tumor Center - Dept. of Medical Oncology, Aarau, CH
G. Pruneri
, European Institute of Oncology, Dept. Of Pathology, Milan, IT
M. Roobol, Erasmus University Medical Center, Dept. of Urology/Epidemiology, Rotterdam, NL
V. Sanchini, European Institute of Oncology, Dept. of Biomedical Humanities, Milan, IT   
M. Schmidinger, Medical University of Vienna, Internal Medicine Clinic I - Dept. of Oncology, Vienna, AT
D. Sebag-Montefiore
, St James' Institute of Oncology - St James' University Hospital, Dept. of Oncology, Leeds, UK
J. Sehouli
, Charité Medical University, Gynaecological Clinic, Berlin , DE
C. Sessa, Oncology Institute of Southern Switzerland, Div. of Medical Oncology, Bellinzona, CH
R. Stahel, University Hospital Zurich, Clinic for Oncology, Zurich, CH
E. Van Cutsem, University Hospital Leuven, Digestive Oncology Dpt., Leuven, BE
E. van Muilekom, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Urology Dpt., Amsterdam, NL
J. Vermorken, Antwerp University Hospital, Dept. of Medical Oncology, Edegem, BE
Y. Wengström, Karolinska Insitutet, Department of Neurobiology, Care Science and Society, Div of Nursing, Huddinge, SE
C. Zielinski, Comprehensive Cancer Center Vienna, Clinical Division of Oncology, Vienna, AT


Programme


 25 March

   
  

Participants' arrival, airport transfers, registration

 12:30 Lunch      
 13:45 Focus on ESO, ESMO and EONS
F.A. Peccatori, IT - R.A. Stahel, CH - B. Grube, DK


 PARALLEL SESSIONS
14:15
Communication Skills Workshop - 2 Groups
A. Arber, UK - A. Hoy, UK       
14:15
Warm up + Case presentations by participants
R.A. Stahel, CH - R. Popescu, CH
15:45

Coffee break
16:00
Communication Skills Workshop - 2 Groups 
A. Arber, UK - A. Hoy, UK
16:00

Warm up + Case presentations by participants
N. Pavlidis, GR - R. Popescu, CH
17:30

Coffee break  
17:45
Communication Skills Workshop - 2 Groups
A. Arber, UK - A. Hoy, UK
 17:45 Warm up + Case presentations by participants 
N. Pavlidis, GR - R.A. Stahel, CH

20:00
Dinner    
   

 

 26 March

   
 8:30 Clinical session Lung cancer I   
Chair: R.A. Stahel, CH
  Surgery   
S. Hillinger, CH   
Radiotherapy   
C. Faivre-Finn, UK
Chemotherapy and targeted treatment    
R.A. Stahel, CH
Immunotherapy of NSCLC   
S. Peters, CH
Small cell lung cancer   
C. Faivre-Finn, UK
Discussion after each lecture    

11:00

 Coffee break  
 11:30 Tumour board Lung cancer    
R.A. Stahel, CH - C. Faivre-Finn, UK - S. Peters, CH
 12:30 Spotlight session Supportive and palliative care
(including early integration of palliative care)   
M. Aapro, CH      
 12:50 Discussion 
 13:00 Lunch
 14:00 Spotlight session Immunotherapy   
O. Michielin, CH
 14:30 Discussion   
 14:40 Spotlight session Melanoma   
O. Michielin, CH
 15:10 Discussion
 15:20  Spotlight session - Sarcomas and GIST
P. Casali, CH
 16:00 

Spotlight session Treatment of elderly cancer patients   
M. Aapro, CH             

 16:20 Discussion   
 18:30  Aperitif with the experts
 19:30 Dinner

   

 

 27 March

   
8:30
 Clinical session Gastro-intestinal tumours   
Chair: D. Sebag-Montefiore, UK  
  

Systemic treatment in adjuvant setting in colon cancer   
A. Cervantes, ES     
Systemic treatment in advanced colon cancer    
E. van Cutsem, BE
      
Management of rectal cancer (surgery and radiotherapy)   
D. Sebag-Montefiore, UK      
Systemic treatment in early and advanced gastric cancer   
F. Lordick, DE     
Pancreatic cancer   
R. Popescu, CH
Discussion after each session  

11:00 Coffee break         
11:30 Tumour board Gastro-intestinal tumours (2 participants' cases + 1 faculty case)   
A. Cervantes, ES - D. Sebag-Montefiore, UK - E. van Cutsem, BE - R. Popescu, CH - F. Lordick, DE
12:30 Spotlight session Molecular tumour boards   
C. Zielinski, AT
12:50 Discussion   
13:00 Lunch
14:00 Case presentations by participants   
N. Pavlidis, GR - R.A. Stahel, CH - R. Popescu, CH
15:30 Spotlight session Magnitude of benefits scale   
C. Zielinski, AT
15:50 Discussion   
 16:00  Spotlight session Drug availability   
A. Eniu, RO
 16:20 Discussion   
 18:30 Aperitif with the experts      
 19:30 
Dinner
   

 

 28 March

   
8:30 Clinical session Breast cancer    
Chair: G. Curigliano, IT  
  Pathology   
G. Pruneri, IT    
Surgery   
W. Gatzemeier, IT

Radiotherapy
   
R. Orecchia, IT      
Treatment of Luminal    
O. Pagani, CH

Treatment of HER-2+
   
A. Eniu, RO      
Treatment of triple negative   
G. Curigliano, IT
Discussion after each session
11:00 Coffee break        
11:30 Tumour board Breast cancer (2 participants' cases + 1 faculty case)   
G. Curigliano, IT - O. Pagani, CH - W. Gatzemeier, AT - R. Orecchia, IT - G. Pruneri, IT - A. Eniu, RO
12:30 Spotlight session Biosimilars   
G. Curigliano, IT
12:50  Discussion   
13:00 Lunch
14.00 Spotlight session Adolescents and young adults   
G. Mountzios, GR  
14:20 Discussion 

14:30  Spotlight session Different roles in the oncology team   
E. van Muilekom
14:50 Discussion
  ETHICAL DILEMMAS WORKSHOP    
15:00 Introduction and presentation of the workshop    
V. Sanchini, IT - P. Maugeri, IT - M. Annoni, IT
15:20 Parallel sessions: Interactive workshop on ethical dilemmas (6 groups)   
V. Sanchini, IT - P. Maugeri, IT - M. Annoni, IT        
16:00
Sum-up on ethical dilemmas   
V. Sanchini, IT - P. Maugeri, IT - M. Annoni, IT
 16:30 Discussion

 18:30 Aperitif with the experts    

 19:30 Dinner + party    
   

 

 29 March

 
8:30 

Clinical session Genito-urinary cancers   
Chair: K. Fizazi, FR
Diagnosis and active surveillance in prostate cancer   
M. Roobol, NL
Initial hormone therapy for metastatic prostate cancer   
S. Gillessen, CH      
Castration-resistant prostate cancer   
K. Fizazi, FR      
Metastatic renal cancer: evidence-based treatment   
M. Schmidinger, CH  
Treatment of bladder cancer   
S. Gillessen, CH
Discussion after each session 

11:30 Coffee break                 
12:00 Tumour board Genito-urinary cancers (2 participants' cases + 1 faculty case)   
K. Fizazi, FR - S. Giellessen, CH -
M. Schmidinger, CH - M. Roobol, NL
13:00 Lunch
14:00 Clinical session Head and neck cancer   
Chair: Jan B. Vermorken, NL  
  

Prognostic factors and surgical approach  
A. Dietz, DE     
Radiotherapy   
R. Orecchia, IT
Systemic therapy and radio- chemo-therapy   
J.B. Vermorken, NL
Discussion after each session 

15:45 Tumour board Head & Neck cancer (1 participants' case + 1 faculty case)   
J.B. Vermorken, NL - R. Orecchia, IT - A. Dietz, DE
16:15 Coffee break           
16:45 Spotlight session Low and high grade lymphomas: recent therapeutic advances   
M. Dreyling, DE
16:20 Discussion
18:30  Aperitif with the experts   

19:30 Dinner
   

 

 30 March

   
 8:30 Clinical session Gynaecological cancers   
Chair: J.B. Vermorken, BE  
  Surgery   
J. Sehouli, DE
Ovarian cancer   

J.B. Vermorken, BE
Cervical and endometrial cancers
C. Sessa, CH
Discussion at the end of each lecture
10:30
  Tumour board Gynaecological cancers    
J.B. Vermorken, BE - C. Sessa, CH - J. Sehouli, DE
11:00  Coffee break
 11:30 Learning assessment test
 12:30 Spotlight session Physical Activity / Exercise and Cancer    Y. Wengström, SE
 12:50 Discussion

 13:00 Closing remarks    
   
   
   
   

Follow us